Jiangsu Eastern ShenghongLtd Valuation

Q: What is the Fair Price of 301 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

000301 (CN¥9.92) is trading above our estimate of [[fair value]] (CN¥1.45)

Is 301 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 301 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 000301 (CN¥9.92) is trading above our estimate of fair value (CN¥1.45)

Significantly Below Fair Value: 000301 is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 301?

Other financial metrics that can be useful for relative valuation.

The above table shows the n/a ratio for 301. This is calculated by dividing 301's market cap by their current preferred multiple.
What is 301's n/a Ratio?
n/a	0x
n/a	n/a
Market Cap	CN¥65.58b

301 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	1.3x
Enterprise Value/EBITDA	22.9x
PEG Ratio	4.1x

Price to Sales Ratio vs Peers

How does 301's PS Ratio compare to its peers?

The above table shows the PS ratio for 301 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PS	Estimated Growth	Market Cap
Peer Average	2x
002648 Satellite ChemicalLtd	1.6x	16.3%	CN¥64.8b
002493 Rongsheng Petrochemical	0.3x	7.1%	CN¥107.3b
600160 Zhejiang Juhua	3x	13.8%	CN¥63.8b
002709 Guangzhou Tinci Materials Technology	3x	20.2%	CN¥40.2b
000301 Jiangsu Eastern ShenghongLtd	0.4x	5.3%	CN¥65.6b

Price-To-Sales vs Peers: 000301 is good value based on its Price-To-Sales Ratio (0.4x) compared to the peer average (2x).

Price to Earnings Ratio vs Industry

How does 301's PE Ratio compare vs other companies in the CN Chemicals Industry?

0 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	n/a	32.1%
	n/a	n/a	n/a

Fetching data

0 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	n/a	32.1%
	n/a	n/a	n/a

No more companies

Price-To-Sales vs Industry: 000301 is good value based on its Price-To-Sales Ratio (0.4x) compared to the CN Chemicals industry average (2.1x).

Price to Sales Ratio vs Fair Ratio

What is 301's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

301 PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio	0.4x
Fair PS Ratio	1x

Price-To-Sales vs Fair Ratio: 000301 is good value based on its Price-To-Sales Ratio (0.4x) compared to the estimated Fair Price-To-Sales Ratio (1x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 301 forecast and predictions for the stock price in 12 month’s time.
Date	Share Price	Average 1Y Price Target	Dispersion	High	Low	1Y Actual price	Analysts
Current	CN¥9.92	CN¥14.00 +41.1%	19.8%	CN¥18.18	CN¥10.40	n/a	5
Apr ’25	CN¥10.16	CN¥14.28 +40.5%	19.4%	CN¥18.18	CN¥10.40	n/a	5
Mar ’25	CN¥10.39	CN¥14.28 +37.4%	19.4%	CN¥18.18	CN¥10.40	n/a	5
Feb ’25	CN¥9.78	CN¥14.28 +46.0%	19.4%	CN¥18.18	CN¥10.40	n/a	5
Jan ’25	CN¥9.60	CN¥15.08 +57.0%	13.3%	CN¥18.18	CN¥12.00	n/a	5
Dec ’24	CN¥9.98	CN¥15.08 +51.1%	13.3%	CN¥18.18	CN¥12.00	n/a	5
Nov ’24	CN¥10.61	CN¥15.08 +42.1%	13.3%	CN¥18.18	CN¥12.00	n/a	5
Oct ’24	CN¥11.55	CN¥15.72 +36.1%	11.5%	CN¥18.18	CN¥13.50	n/a	5
Sep ’24	CN¥11.55	CN¥16.76 +45.1%	14.9%	CN¥21.00	CN¥13.50	n/a	6
Aug ’24	CN¥12.74	CN¥17.88 +40.3%	14.3%	CN¥21.00	CN¥15.00	n/a	5
Jul ’24	CN¥11.82	CN¥18.28 +54.7%	13.7%	CN¥21.00	CN¥15.00	n/a	6
Jun ’24	CN¥11.36	CN¥18.28 +60.9%	13.7%	CN¥21.00	CN¥15.00	n/a	6
May ’24	CN¥12.67	CN¥18.28 +44.3%	13.7%	CN¥21.00	CN¥15.00	CN¥9.92	6
Apr ’24	CN¥13.62	CN¥20.55 +50.9%	2.0%	CN¥21.00	CN¥20.00	CN¥10.16	4
Mar ’24	CN¥15.40	CN¥20.55 +33.4%	2.0%	CN¥21.00	CN¥20.00	CN¥10.39	4
Feb ’24	CN¥16.01	CN¥21.40 +33.7%	8.0%	CN¥24.30	CN¥20.00	CN¥9.78	4
Jan ’24	CN¥13.04	CN¥21.40 +64.1%	8.0%	CN¥24.30	CN¥20.00	CN¥9.60	4
Dec ’23	CN¥13.79	CN¥21.77 +57.8%	8.4%	CN¥24.30	CN¥20.00	CN¥9.98	3
Nov ’23	CN¥12.57	CN¥21.17 +68.4%	9.0%	CN¥24.30	CN¥19.36	CN¥10.61	4
Oct ’23	CN¥17.42	CN¥24.92 +43.0%	14.5%	CN¥29.00	CN¥19.36	CN¥11.55	4
Sep ’23	CN¥18.81	CN¥23.82 +26.6%	16.7%	CN¥29.00	CN¥19.36	CN¥11.55	3
Aug ’23	CN¥20.01	CN¥21.12 +5.5%	11.9%	CN¥24.00	CN¥18.00	CN¥12.74	4
Jul ’23	CN¥17.09	CN¥21.12 +23.6%	11.9%	CN¥24.00	CN¥18.00	CN¥11.82	4
Jun ’23	CN¥15.24	CN¥21.12 +38.5%	11.9%	CN¥24.00	CN¥18.00	CN¥11.36	4
May ’23	CN¥12.25	CN¥25.43 +107.6%	14.5%	CN¥30.80	CN¥21.00	CN¥12.67	4

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.